Camelot Portfolios’s Dorman Products DORM Stock Holding History

Camelot Portfolios’s Portfolio DORM Stock Details DORM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,060	Closed	-$131K	–	284
2025 Q4	$131K	Buy	+1,060	New	+$143K	0.08%	214
2024 Q3	–	Sell	-1,060	Closed	-$97K	–	250
2024 Q2	$97K	Buy	+1,060	New	+$97K	0.05%	255

Other funds holding DORM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Camelot Portfolios's DORM Position: Q1 2026 in Review

Camelot Portfolios sold out of Dorman Products (DORM) in Q1 2026, closing a stake of 1,060 shares — an estimated $131K sold.

Camelot Portfolios first reported a position in DORM in Q2 2024 and held it in 2 quarters. The position peaked at $131K in Q4 2025. 319 funds tracked by Wall St. Rank hold DORM as of Q1 2026.

Camelot Portfolios reported no remaining Dorman Products position as of Q1 2026 after selling out during the quarter.
Camelot Portfolios sold 1,060 Dorman Products shares in Q1 2026, an estimated $131K.
Camelot Portfolios first reported a position in Dorman Products in Q2 2024 and held it in 2 quarters.
Camelot Portfolios's Dorman Products position peaked at $131K in Q4 2025.
319 funds tracked by Wall St. Rank held Dorman Products as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.